Skip to content

CHEMBIO DIAGNOSTICS, INC.: 10-Q filed 2015-11-12

What CHEMBIO DIAGNOSTICS, INC. reported in its quarterly report filed 2015-11-12 (fiscal Q3 2015): 32 published measures, 94 facts as tagged in accession 0001092662-15-000089.

This filing

Form
10-Q (quarterly report)
Filed
2015-11-12
Fiscal period
fiscal Q3 2015
Accession
0001092662-15-000089 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHEMBIO DIAGNOSTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-09-3022,808,103USD
At 2014-12-3125,010,192USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-09-304,564,150USD
At 2014-12-315,286,030USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-09-3018,243,953USD
At 2014-12-3119,724,162USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-09-301,102,477USD
At 2014-12-314,614,538USD
At 2014-09-303,672,702USD
At 2013-12-319,650,275USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-437,157USD92
2015-01-01 to 2015-09-30-1,748,059USD273
2014-07-01 to 2014-09-30-270,621USD92
2014-01-01 to 2014-09-30-641,341USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-09-30-29,676,435USD
At 2014-12-31-27,928,376USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2015-07-01 to 2015-09-309,628,248shares92
2015-01-01 to 2015-09-309,625,282shares273
2014-07-01 to 2014-09-309,611,139shares92
2014-01-01 to 2014-09-309,503,084shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2015-07-01 to 2015-09-309,628,248shares92
2015-01-01 to 2015-09-309,625,282shares273
2014-07-01 to 2014-09-309,611,139shares92
2014-01-01 to 2014-09-309,503,084shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-0.05USD/shares92
2015-01-01 to 2015-09-30-0.18USD/shares273
2014-07-01 to 2014-09-30-0.03USD/shares92
2014-01-01 to 2014-09-30-0.07USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-0.05USD/shares92
2015-01-01 to 2015-09-30-0.18USD/shares273
2014-07-01 to 2014-09-30-0.03USD/shares92
2014-01-01 to 2014-09-30-0.07USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-142,300USD92
2015-01-01 to 2015-09-30-603,370USD273
2014-07-01 to 2014-09-309,284USD92
2014-01-01 to 2014-09-30-237,916USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-09-302,622,003USD
At 2014-12-312,797,929USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-09-30267,850USD273
2014-01-01 to 2014-09-30336,407USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-579,061USD92
2015-01-01 to 2015-09-30-2,352,524USD273
2014-07-01 to 2014-09-30-262,473USD92
2014-01-01 to 2014-09-30-878,077USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-09-3015,165,035USD
At 2014-12-3117,658,199USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-07-01 to 2015-09-30749USD92
2015-01-01 to 2015-09-30749USD273
2014-07-01 to 2014-09-300USD92
2014-01-01 to 2014-09-300USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-09-304,564,150USD
At 2014-12-315,286,030USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-09-309,514,951USD
At 2014-12-318,338,889USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-07-01 to 2015-09-303,489,595USD92
2015-01-01 to 2015-09-3010,968,808USD273
2014-07-01 to 2014-09-302,912,863USD92
2014-01-01 to 2014-09-308,783,628USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-09-303,010,537USD
At 2014-12-313,638,299USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-302,910,534USD92
2015-01-01 to 2015-09-308,616,284USD273
2014-07-01 to 2014-09-302,650,390USD92
2014-01-01 to 2014-09-307,905,551USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2015-07-01 to 2015-09-301,919,551USD92
2015-01-01 to 2015-09-306,057,221USD273
2014-07-01 to 2014-09-301,940,424USD92
2014-01-01 to 2014-09-305,344,914USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-07-01 to 2015-09-301,570,044USD92
2015-01-01 to 2015-09-304,911,587USD273
2014-07-01 to 2014-09-30972,439USD92
2014-01-01 to 2014-09-303,438,714USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-09-309,628,248shares
At 2014-12-319,611,139shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-09-3047,824,105USD
At 2014-12-3147,556,426USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-09-301,537,070USD
At 2014-12-311,066,473USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-579,457USD92
2015-01-01 to 2015-09-30-2,351,429USD273
2014-07-01 to 2014-09-30-261,337USD92
2014-01-01 to 2014-09-30-879,257USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-01-01 to 2015-09-30981,579USD273
2014-01-01 to 2014-09-30536,791USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-396USD92
2015-01-01 to 2015-09-301,095USD273
2014-07-01 to 2014-09-301,136USD92
2014-01-01 to 2014-09-30-1,180USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2015-01-01 to 2015-09-30-603,370USD273
2014-01-01 to 2014-09-30-239,342USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-09-301,176,062USD273
2014-01-01 to 2014-09-303,723,530USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-09-30-627,762USD273
2014-01-01 to 2014-09-30786,524USD273

Inspect the source

Entity
CHEMBIO DIAGNOSTICS, INC. / CIK 0001092662
Captured
SEC response SHA-256
f4e40937d0d95fb11dba8f52939536a64af75af5fd3640d428deb7a120351716

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001092662.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))